List of works - Argiris Symeonidis

"Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group.

scientific article

(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.

scientific article

A multicenter cross-sectional study of the quality of life and iron chelation treatment satisfaction of patients with transfusion-dependent β-thalassemia, in routine care settings in Western Greece

scientific article published on 13 September 2020

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.

scientific article published on 19 June 2017

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

scientific article published on 30 March 2018

A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.

scientific article published in April 2003

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece.

scientific article published on 4 November 2016

A revised international prognostic score system for Waldenström's macroglobulinemia

scientific article published on 22 May 2019

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow

scientific article published on 26 July 2015

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

scientific article published on 17 January 2017

Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

scientific article

Allogeneic stem cell transplantation from donors with mosaic Turner syndrome

scientific article published on 01 September 2006

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)

scientific article published on 01 July 2019

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome

scientific article published on 15 March 2019

Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry

scientific article published on 28 September 2019

Choroidal Thickness Evaluation in a Transfusion-Dependent Beta-Thalassemia Greek Population

scientific article published on 24 December 2020

Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

scientific article published on 14 November 2018

Chronic neutrophilic leukemia with dysplastic features. A new variant of the myelodysplastic syndromes

scientific article published on 01 January 1989

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

scientific article

Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data

scientific article

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

scientific article published on 20 August 2015

Constitutional pericentric inversion of chromosome 9 and hematopoietic recovery after allogeneic stem cell transplantation

scientific article published on 07 June 2006

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

scientific article published on 01 September 2018

Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy.

scientific article published on 21 October 2016

Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes

scientific article published on January 1, 1992

Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal.

scientific article

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

article

Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.

scientific article published on 26 May 2009

Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma

scientific article published on 22 January 2019

Effect of the gonadotropin-releasing hormone antagonist cetrorelix on the prevention of chemotherapy-induced ovarian damage in women with hematological malignancy

scientific article published on 12 April 2012

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group

scientific article published on 27 July 2019

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.

scientific article published on June 2015

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

scientific article

Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes

scientific article

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

scientific article published in February 2002

Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients' survival.

scientific article published on 28 March 2007

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients

scientific article published on 01 July 2019

Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients

scientific article published on 19 February 2016

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel anti-myeloma therapies.

scientific article

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

scientific article

Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis

scientific article published on 01 October 1991

Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents

scientific article published on 26 January 2014

Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea

scientific article published on 01 October 2018

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

scientific article published on 06 June 2019

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

scientific article published on 05 July 2019

Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state.

scientific article published in August 2004

Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome

scientific article published on 01 September 2004

Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients

scientific article published on 01 April 2001

Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus

scientific article published on 31 August 2005

Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia

scientific article published on 01 June 2006

Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.

scientific article

Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes

scientific article published on 01 January 1991

Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.

scientific article published in January 2004

Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes.

scientific article

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

scientific article

Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.

scientific article published in August 2006

Macrophage Inflammatory Protein-1 alpha (MIP-1alpha) is over-expressed in a cohort of patients with myelodysplastic syndromes

scientific article published on 01 July 2005

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

scientific article published on 24 October 2016

Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.

scientific article published in July 2012

No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years

scientific article published on 20 April 2011

Non hypoxia-related splenic infarct in a patient with sickle cell trait and infectious mononucleosis.

scientific article published on January 2001

Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

scientific article published on 19 January 2017

Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression

scientific article published on 01 August 2002

Overexpression of phosphorylated p27 Kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.

scientific article published on 21 February 2011

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

scientific article

Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.

scientific article published on January 2011

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes

scientific article

Polyploidy in acute promyelocytic leukemia without the 15:17 translocation

scientific article published on 01 December 2001

Predictors of mortality for KPC-producing Klebsiella pneumoniae bloodstream infections in adult neutropenic patients with haematological malignancies

scientific article published on 25 March 2020

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.

scientific article

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

scientific article published on 18 June 2007

Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group

scientific article published on 01 January 2007

Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia

scientific article published on 01 January 1990

Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.

scientific article

Prognostication of the High-Risk WM Patient

scientific article published on 01 February 2011

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.

scientific article published in July 2002

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

scientific article

Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease

scientific article published on 01 January 2006

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

scientific article published on 25 June 2019

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

scientific article published on 13 May 2018

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.

scientific article published on 9 March 2018

Relative iron "overload" in offspring of patients with type 2 diabetes mellitus: a new component in the conundrum of insulin resistance syndrome?

scientific article published in July 2003

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

scientific article published on 10 March 2009

Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study

scientific article published on 01 January 2019

Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease

scientific article

Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.

scientific article

Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease

scientific article published on 08 November 2010

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.

scientific article published on 13 January 2012

Tc-99m Depreotide SPECT/CT depicts myocardial involvement in a case of thrombotic thrombocytopenic purpura.

scientific article

Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.

scientific article published on 27 August 2010

The Burden of Myelofibrosis In Greece

scientific article published on 26 October 2014

The incidence of myelodysplastic syndromes in Western Greece is increasing.

scientific article published on 10 April 2013

The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.

scientific article published in September 2004

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.

scientific article published on 21 March 2019

The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine. A retrospective analysis of the Hellenic (Greek) MDS Study Group.

scientific article published on 16 April 2018

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

scientific article published on 18 September 2020

Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group

scientific article published on 21 November 2013

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.

scientific article

Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients

scientific article published on 23 October 2017

List of works by Argiris Symeonidis

"Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group.

(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.

A multicenter cross-sectional study of the quality of life and iron chelation treatment satisfaction of patients with transfusion-dependent β-thalassemia, in routine care settings in Western Greece

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece.

A revised international prognostic score system for Waldenström's macroglobulinemia

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

Allogeneic stem cell transplantation from donors with mosaic Turner syndrome

Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome

Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry

Choroidal Thickness Evaluation in a Transfusion-Dependent Beta-Thalassemia Greek Population

Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

Chronic neutrophilic leukemia with dysplastic features. A new variant of the myelodysplastic syndromes

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

Constitutional pericentric inversion of chromosome 9 and hematopoietic recovery after allogeneic stem cell transplantation

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy.

Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes

Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal.

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.

Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma

Effect of the gonadotropin-releasing hormone antagonist cetrorelix on the prevention of chemotherapy-induced ovarian damage in women with hematological malignancy

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients' survival.

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients

Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel anti-myeloma therapies.

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis

Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents

Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state.

Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome

Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients

Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus

Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia

Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.

Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes

Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.

Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes.

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.

Macrophage Inflammatory Protein-1 alpha (MIP-1alpha) is over-expressed in a cohort of patients with myelodysplastic syndromes

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.

No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years

Non hypoxia-related splenic infarct in a patient with sickle cell trait and infectious mononucleosis.

Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression

Overexpression of phosphorylated p27 Kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes

Polyploidy in acute promyelocytic leukemia without the 15:17 translocation

Predictors of mortality for KPC-producing Klebsiella pneumoniae bloodstream infections in adult neutropenic patients with haematological malignancies

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group

Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia

Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.

Prognostication of the High-Risk WM Patient

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

Pure infradiaphragmatic Hodgkin's lymphoma. Clinical features, prognostic factor and comparison with supradiaphragmatic disease